TORONTO, ON and NEW YORK, NY --(Marketwired - June 13, 2017) -
iAnthus Capital Holdings, Inc. ("iAnthus" or "the Company"), (CSE: IAN) (OTCQB: ITHUF), which owns, operates, and partners with licensed cannabis operations throughout the United
States, is pleased to announce that Hadley Ford, Chief Executive Officer, will present at the 6th Annual Marcum
MicroCap Conference at the Grand Hyatt Hotel in New York on Thursday, June 15, 2017 at 9:30 a.m. Eastern Time.
iAnthus announced earlier this week that they have signed a binding letter of intent to acquire 100% of Valley
Agriceuticals, LLC. ("Valley Ag"), which has conditional approval from the New York State Department of Health to be awarded one
of just ten medical marijuana licenses issued by the state . The proposed acquisition, when closed, will expand iAnthus'
portfolio into five regulated cannabis states in the U.S., which the Company believes will constitute the largest footprint among
public companies focused on licensed cannabis operations in the U.S.
Hadley Ford, Chief Executive Officer of iAnthus, commented, "We look forward to the proposed expansion into New
York, which we believe has the potential to be one of the largest medical marijuana markets in the U.S. due to its large
population and rapidly growing patient base. With this expansion, iAnthus is well positioned to harness the growth in the legal
cannabis market, which is the fastest growing industry in the United States. We welcome the opportunity to update the investment
community on our current licensed operations and growth strategy at the Marcum Conference."
The presentation will offer the investment community an opportunity to hear about iAnthus' cannabis operations
and expansion strategy. The management of iAnthus will also be available for one-on-one meetings at the conference on Thursday,
June 15, 2017 and Friday, June 16, 2017. Investors interested in arranging a meeting should contact their Marcum
representative.
To be added to the email distribution list, please email iAnthus@kcsa.com with "iAnthus" in the subject line.
Please see iAnthus' news release dated June 12, 2017 (a copy is available under the Company's SEDAR profile at
www.sedar.com) for further information on the proposed transaction with Valley
Ag and the conditions to closing.
About iAnthus Capital Holdings, Inc.
iAnthus Capital Holdings, Inc. provides investors diversified exposure to best-in-class licensed cannabis
cultivators, processors and dispensaries throughout the United States. Founded by entrepreneurs with decades of experience in
investment banking, corporate finance, law and healthcare services, iAnthus provides a unique combination of capital and hands-on
operating and management expertise. The Company leverages these skills to support a diversified portfolio of cannabis industry
investments for our shareholders. For more information, visit www.iAnthuscapital.com.
About Marcum Microcap Conference
The Marcum MicroCap Conference is an annual highlight on the investment community calendar. Since its launch in
2012, the event has become a nationally recognized forum for publicly traded companies with less than $500 million in market
capitalization to network with fund managers and high net worth investors who focus on small cap equities. More than 2,000
participants from all segments of the microcap market participate each year, including senior management, finance and legal
executives, venture and lower middle-market private equity investors, institutional investors, directors, investment bankers,
buy- and sell- side analysts, and service providers to the microcap marketplace. The 2017 Conference will take place over the
two-day period of June 15-16 at the Grand Hyatt Hotel in New York City.
Forward Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties
concerning the specific factors disclosed here and elsewhere in iAnthus' periodic filings with Canadian securities regulators.
When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and
similar expressions, are forward-looking statements.
Forward-looking statements may include, without limitation, statements relating to the acquisition of final
registration as a registered organization in New York State, the expected date of the closing of the proposed acquisition, and
potential for patient growth in New York State.
Although iAnthus has attempted to identify important factors that could cause actual results, performance or
achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause
results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence
on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are
engaged in activities currently considered illegal under US Federal laws; change in laws; limited operating history; reliance on
management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent
public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.
There can be no assurance that such information will prove to be accurate or that management's expectations or
estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the
results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking
statements in this news release are made as of the date of this release. iAnthus disclaims any intention or obligation to update
or revise such information, except as required by applicable law, and iAnthus does not assume any liability for disclosure
relating to any other company mentioned herein.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news
release.